A detailed history of Seven Eight Capital, LP transactions in Haleon PLC stock. As of the latest transaction made, Seven Eight Capital, LP holds 109,376 shares of HLN stock, worth $1.03 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
109,376
Holding current value
$1.03 Million
% of portfolio
0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.32 - $10.7 $910,008 - $1.17 Million
109,376 New
109,376 $1.16 Million
Q3 2023

Nov 14, 2023

BUY
$7.85 - $8.94 $25,261 - $28,768
3,218 Added 32.03%
13,265 $110,000
Q2 2023

Aug 14, 2023

BUY
$8.04 - $9.0 $80,777 - $90,423
10,047 New
10,047 $84,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.